Pediatric onset multiple sclerosis

K Deiva

doi:10.1016/j.neurol.2019.02.002

Pediatric onset multiple sclerosis

Rev Neurol (Paris). 2020 Jan-Feb;176(1-2):30-36. doi: 10.1016/j.neurol.2019.02.002. Epub 2019 May 12.

Author

K Deiva¹

Affiliation

¹ Service de neurologie pédiatrique, CRMR maladies inflammatoires rares du cerveau et de la moelle (MIRCEM), assistance publique-hôpitaux de Paris, hôpitaux universitaires Paris-Sud, Site Bicêtre, 72, rue G-Leclerc, 94275 Le Kremlin Bicêtre, France; Inserm UMR1184 « Immunology of viral infections and autoimmune diseases », CEA, IDMIT, faculté de médecine Paris Sud-XI, faculté de médecine Paris-Sud, 63, rue Gabriel-Peri 94276 Le Kremlin-Bicêtre, France. Electronic address: kumaran.deiva@aphp.fr.

PMID: 31088692
DOI: 10.1016/j.neurol.2019.02.002

Abstract

Multiple Sclerosis (MS) is the commonest among inflammatory demyelinating diseases. While the disease prevalence is high in adults, frequency of pediatric onset multiple sclerosis (POMS) is very low in children and particularities in this population have been identified. We will address in this review characteristics of POMS.

Keywords: Clinical Neuroscience; Neuroimmunology; Pediatric Neurology.

Publication types

Review

MeSH terms

Adult
Age of Onset
Child
Humans
Multiple Sclerosis / diagnosis*
Multiple Sclerosis / epidemiology*
Multiple Sclerosis / therapy
Pediatrics* / methods
Pediatrics* / statistics & numerical data
Prevalence